P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 21, 2002, Pages 3199-3202

  Priestley, E Scott ^a   De Lucca, Indawati ^a   Ghavimi, Bahman ^a   Erickson Viitanen, Susan ^a   Decicco, Carl P ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORONIC ACID DERIVATIVE; CHYMOTRYPSIN; ELASTASE; PROTEINASE INHIBITOR;

ARTICLE; CRYSTAL STRUCTURE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; STRUCTURE ACTIVITY RELATION;

ANTIVIRAL AGENTS; BORONIC ACIDS; CHYMOTRYPSIN; HEPACIVIRUS; HUMANS; INDICATORS AND REAGENTS; LEUKOCYTES; PANCREAS; PANCREATIC ELASTASE; PEPTIDES; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 0037020760     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00682-0     Document Type: Article

References (29)

1. Lauer G.M., Walker B.D. N. Engl. J. Med. 345:2001;41.
2. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M.-H., Albrecht J.K. the International Hepatitus Interventional Therapy Group Lancet. 358:2001;958.
3. Bartenschlager R., Lohmann V. J. Gen. Virol. 81:2000;1631.
4. Bartenschlager R. J. Viral Hepatitis. 6:1999;165.
5. Love R.A., Parge H.E., Wickersham J.A., Hostomsky Z., Habuka N., Moomaw E.W., Adachi T., Hostomska Z. Cell. 87:1996;331.
6. Kim J.L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.A., O'Malley E.T., Harbeson S.L., Rice C.M., Murko M.A., Caron P.R., Thomson J.A. Cell. 87:1996;343.
7. Yao N., Reichert P., Taremi S.S., Prosise W.W., Weber P.C. Structure. 7:1999;1353.
8. Di Marco S., Rizzi M., Volpari C., Walsh M.A., Narjes F., Colarusso S., De Francesco R., Matassa V.G., Sollazzo M. J. Biol. Chem. 275:2000;7152.
9. Kolykhalov A.A., Agapov E.V., Blight K.J., Mihalik K., Feinstone S.M., Rice C.M. Science. 277:1997;570.
10. Kolykhalov A.A., Mihalik K., Feinstone S.M., Rice C.M. J. Virol. 74:2000;2046.
11. For a description of the protease nomenclature, see: Schechter I., Berger A. Biochem. Biophys. Res. Commun. 27:1967;157.
12. Kettner C.A., Shenvi A.B. J. Biol. Chem. 259:1984;15106.
13. Urbani A., Bianchi E., Narjes F., Tramontano A., De Francesco R., Steinkühler C., Pessi A. J. Biol. Chem. 272:1997;9204.
14. Zhang R., Durkin J., Windsor W.T., McNemar C., Ramanathan L., Le H.V. J. Virol. 71:1997;6208.
15. Llinàs-Brunet M., Bailey M., Fazal G., Goulet S., Halmos T., Laplante S., Maurice R., Poirier M., Poupart M.-A., Thibeault D., Wernic D., Lamarre D. Bioorg. Med. Chem. Lett. 8:1998;1713.
16. Llinàs-Brunet M., Bailey M., Déziel R., Fazal G., Gorys V., Goulet S., Halmos T., Maurice R., Poirier M., Poupart M.-A., Rancourt J., Thibeault D., Wernic D., Lamarre D. Bioorg. Med. Chem. Lett. 8:1998;2719.
17. Ingallinella P., Altamura S., Bianchi E., Taliani M., Ingenito R., Cortese R., De Francesco R., Steinkühler C., Pessi A. Biochemistry. 37:1998;8906.
18. Matteson D.S., Majumdar D. J. Am. Chem. Soc. 102:1980;7588.
19. Matteson D.S., Ray R. J. Am. Chem. Soc. 102:1980;7590.
20. Matteson D.S., Majumdar D. Organometallics. 2:1983;1529.
21. Matteson D.S., Sadhu K.M. J. Am. Chem. Soc. 103:1981;5241.
22. All intermediates gave satisfactory NMR and mass spectral data. Peptide boronic acids 1-32 were characterized by high resolution mass spectrometry and analytical HPLC.
23. Brown H.C., Gupta S.K. J. Am. Chem. Soc. 97:1975;5249.
24. Compounds were tested for enzyme inhibition as their pinanediol esters, as it has been demonstrated that boronic acid pinanediol esters are rapidly hydrolyzed to the free boronic acid in dilute aqueous solution (see ref 12 ).
25. m=20 μM.
26. Human neutrophil elastase was obtained from ART Biochemicals, Athens, Georgia. Stock solutions of lyophilized enzyme (1 mg/mL) were prepared in PBS buffer containing 10% glycerol and stored at -20 °C. Human neutrophil elastase was assayed with the Meo-Suc-Ala-Ala-Pro-Val-p-nitroanilide (Sigma) as a substrate ( ref 12 ). The hydrolysis of substrate was monitored at 405 nm on a Hewlett-Packard spectrophotometer. Kinetic parameters were determined in PBS buffer at room temperature with concentration of DMSO did not exceed 2%.
27. 2 buffer at room temperature with a concentration of DMSO that did not exceed 2%.
28. Wienand A., Ehrhardt C., Metternich R., Tapparelli C. Bioorg. Med. Chem. 7:1999;1295.
29. Deadman J.J., Elgendy S., Goodwin C.A., Green D., Baban J.A., Patel G., Skordalakes E., Chino N., Claeson G., Kakkar V.V., Scully M. F. J. Med. Chem. 38:1995;1511.